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Introduction 
 
Pulmonary rehabilitation is an integrative part of management of patients with chronic 
obstructive pulmonary disease (COPD).  Randomized, controlled trials showed as an 
evidence that exercise training improves exercise capacity and quality of life in COPD (1).  
Breathlessness and peripheral muscle dysfunction are the pri mary reasons for decreased 
ability to perform normal activities and reduce quality of life (1).  Exercise training has 
favorable effects on breathing, circulation and metabolism (2).  These physiologic effects 
depend on training frequency, intensity, modality, and duration (3-9). 
The aim of several research groups was to determine the relative effectiveness of 
interval training (higher intensity alternated with lower intensity periods) compared to 
constant work rate (continuous) exercise training.  In healthy subjects some (10, 11), but not 
all (12-14), studies have showed superior effect in selected physiologic parameters in interval 
vs. continuous training.  In COPD, two studies have not found differences between these 
training strategies (4, 8).  Ambrosino reviewed studies about interval training and has found 
that it leads to higher physiologic benefit in peak oxygen consumption and peak work rate, a 
greater improvement in lactate threshold, and this type of training is more easily accepted, 
especially in elderly people (15).  It was concluded that in COPD patients, there were no 
exact results about the superiority of high intensity bilevel interval training (15).  There might 
be some controversy in the effectiveness of self-paced training programs.  While these 
programs have favourable effects, like improved exercise capacity, reduced breathlessness 
and improved quality of life (9), the relative influence of this training modality compared to 
supervised training programs remains unclear (6, 7). 
Exercise intolerance is one of the principal determining factor in quality of life, 
especially in advanced stages of COPD (16).  Reduced ventilatory capacity can have large 
impact in exercise intolerance in patients with severe COPD, mainly affected by expiratory 
flow limitation (EFL) related to elevated airway resistance and decreased elastic recoil (17-
20).   
The main element of EFL is increased airway resistance as it leads a series of changes 
in other modulators of airflow (21).  Increased intrathoracic pressure is generated because the 
rise in resistance leads to prolonged time constants of the airways, and higher pressure is 
needed to drive flow (22).  Higher pressure results in increased gas compression and dynamic 
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airway compression in the airways (23-25).  All of these components result in intrabreath 
reduction of flow (17, 19, 23-25) presenting in a concave shape on the expiratory flow-
volume curve – as an indication of flow falling quickly after expiration starts.   
Several methods have sought to evaluate EFL during exercise (26-30).  One method 
has the advantage of the fact that EFL achieves the point when expiratory flow turns to 
independent of driving pressure, i.e. the flow does not increase when negative expiratory 
pressure (NEP) is applied at the mouth (28).  Forced oscillation technique is another way to 
detect EFL, which is based on the concept that oscillatory pressure cannot pass through flow-
limiting airway segments, the consequences of this phenomenon are reduced apparent 
compliance and respiratory system input reactance (29).  Although both NEP and forced 
oscillation techniques offer a reliable method to quantify EFL during spontaneous breathing, 
the implementation of either method is a methodical challenge and even if successful has 
limitations because both methods require cooperation from the subject that can be difficult to 
achieve during exercise. The forced oscillation technique requires complex instrumentation 
with a breathing technique that allows a free passage through the oropharynx and glottis (30) 
and the measurement takes about 20 seconds. The NEP method can only be applied 
intermittently and the necessitates comparison of expiratory flow profiles with and without 
the application of NEP (28).   
The expiratory limb of the maximal flow-volume loop in a classic forced expiratory 
spirometry shows concavity in patients with obstructive airway disease and that concavity 
becomes more prominent with the more seve airflow obstruction. Therefore, we hypothesized 
that EFL can be assessed quantitatively by detecting the configuration of spontaneous 
expiratory flow-volume (SEFV) curves during rest and exercise on a breath-by-breath basis.  
This method does not require any change in physiologic breathing pattern or alteration of the 
usual procedures used in cardiopulmonary exercise testing (31, 32).  Relevant information of 
EFL may be gained from the shape of SEFV curves because, as stated above, changes in the 
variables related to EFL (i.e. dynamic airway compression, gas compression and the time 
constants of involved lung compartments) are predictably reflected in intrabreath changes of 
flow.  Moreover, in presence of EFL, flow rates of spontaneous expirations are based on 
mechanisms similar to those influencing forced expirations (25, 33), which have been 
considered to be valuable methods to characterize EFL (34-37).  This implies that the shape 
of SEFV curves, especially the degree of its concavity, might be useful to quantify the 
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augmentation of EFL as exercise gathers and the minute ventilation approaches breathing 
capacity.   
In this methodological part of the thesis our goal was to develop computerized 
analysis to quantify the configuration of the spontaneous flow-volume profile on a breath-by-
breath basis throughout during exercise, with special detection of the development of EFL in 
moderate to severe COPD patients.  To gain a preliminary appreciation of the potential of this 
technique, and before comparing it with the previously mentioned known methods, we also 
made a comparison between the spontaneous expiratory flow-volume responses in COPD 
patients and age-matched healthy individuals.  In addition, the relation between the degree of 
SEFV curve concavity and measures of ventilatory limitation during exercise (i.e. VE/MVV) 
was also investigated.   
 
Aims of the study 
Study I. 
In Study I we sought determining the relative effectiveness of supervised continuouos, 
interval and home-based training in COPD.  We intended that it would have great practical 
importance   
• to determine whether there were differences in the improvements in exercise tolerance 
or perceived activity levels between these three training modalities,  
• to compare maximal work rate, metabolic profile (gas exchange, lactate threshold), 
ventilatory and circulatory differences between these groups 
• to assess and follow-up symptoms related to quality of life after different 
rehabilitation programs. 
The results of this study might help to develop practical guidance for rehabilitation 
professionals seeking to institute effective rehabilitative interventions for patients with 
COPD. 
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Study II. 
With the intention of continuous, breath by breath monitoring we aimed to develop 
computerized procedures to quantify the configuration changes of the spontaneous flow-
volume curve during exercise in severe COPD patients. Our specific aims were: 
• to gain a preliminary appreciation of the accuracy of this technique according to the 
spontaneous expiratory flow-volume responses in a group of COPD patients and a 
group of age-matched healthy individuals, 
• to detect EFL by investigation of the spontanouos flow-volume loops in moderate to 
severe COPD patients,  
• to analyze the comparison of detecting EFL and exercise intolerance of COPD 
patients. 
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Materials and Methods 
Study subjects 
Study I 
Seventy-one stable patients with very severe to moderate COPD ((forced expired 
volume in one second (FEV1) range: 21-94% pred)) (38) participated in study I; none of them 
qualified for long-term oxygen therapy.   The study was approved by the local ethical 
committee and the patients gave their written consent to their participation.  Subjects were 
screened for severe cardiovascular, neurological or exercise-limiting joint disorders that 
would have precluded full participation in the training protocol.  Eight subjects were 
excluded from 79 screened patients: 1 with psychiatric disease, 4 with ischemic heart disease 
and 3 had exercise-limiting joint disease. 
 Study II 
Seventeen men and women with the diagnosis of moderate to severe COPD 
participated in the study.  COPD individuals with (FEV1) ≤60% of predicted were included 
(38).  Individuals with acute respiratory exacerbation, with the diagnosis or symptoms of a 
significant cardiac disease, requiring chronic supplemental oxygen, having resting oxygen 
saturation <89% measured by pulse oximetry, and who were exercise-limited by orthopedic 
or joint related diseases were excluded.  Twelve healthy age-matched men and women were 
also involved.  All subjects were informed and they signed the written informed consent for 
their participation.  The study was approved by the Institutional Review Board of the Los 
Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. 
 
Pulmonary function and exercise test 
Each subject performed a series of pulmonary function test (Vmax 229 and Autobox 
6200, VIASYS Sensormedics, Yorba Linda, California, USA) including spirometry, body 
plethysmography and diffusion capacity measurement. COPD patients took 400 µg of 
salbutamol (in study I) and 400 µg of albuterol (in study II) by inhalation via a spacer 20 
minutes before testing in order to maximize bronchodilation.  All pulmonary function tests 
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fulfilled the ATS/ERS guidelines (38).  Normal values for spirometry were calculating using 
the NHANES III standard (38).   
An incremental symptom-limited exercise test was performed on an electrically 
braked cycle ergometer (Ergoline 800, VIASYS SensorMedics) with a pedaling rate of 60 
revolutions per minute.  After 3 minutes of rest and 3 minutes of loadless pedaling, the work 
rate was increased by 5-15 watts (W) per minute in a ramp fashion (increment was 5 W/min 
if FEV1<1.0 L, 10 W/min if FEV1 >1.0 L for the COPD patients; increment rate was 15 
W/min for the healthy subjects).  Pedaling rate was kept constant at approximately 60 rpm.  
Pulmonary ventilation ( EV& ) and gas exchange ((oxygen uptake ( 2VO& ) and carbon-dioxide 
output ( 2VCO& )) were measured breath-by-breath by a mass flow-sensor and exercise 
metabolic measurement system (Vmax Spectra, SensorMedics).  The system was calibrated 
before each test.  Lactic acidosis threshold (LAT) was identified by the modified V-slope 
method (39).  Heart rate, 12-lead ECG (Cardiosoft, GE Electric/SensorMedics) and oxygen 
saturation by pulse oximetry (Radical 7, Masimo) was monitored.  Blood gas analysis was 
done from capillary blood taken from a hyperemic earlobe at rest and peak exercise (AVL 
Omni7, Ramsey, Minnesota) in study I.  Maximal voluntary ventilation was estimated as 
40xFEV1 (40).  Shortness of breath and leg fatigue was assessed by the Borg category ratio 
scale every two minutes during exercise (41).  Isotime response, defined as response at the 
time the shorter of the pre- and post-training incremental exercise test ended, was calculated 
for several physiological variables. 
Study design for Study I 
Patients were divided into three groups: C, supervised continuous, n=22; I, supervised 
interval, n=17; and S, home-based and self-paced, n=32 (Table 1).  Patients who lived in the 
vicinity of the training center and could attend outpatient training sessions were randomized 
(without stratification) to C or I; those unable to attend supervised training due to 
unreasonable travel distances were assigned to self-paced training.  C and I groups performed 
exercise training 3 times/week for 45 minutes during an 8-week period.  Group C exercise 
intensity was 80% of peak work rate achieved in an incremental exercise test.  Interval 
training involved a 30 min period of cycling for 2 minutes at 90% followed by 1 minute at 
50% peak work rate.  This 30 min period was preceded and followed by approximately 7.5 
min of exercise at 50% peak work rate (warm-up and cool-down phase).  The S group was 
  
14
instructed to cycle, climb stairs and walk in their natural environment with the same weekly 
periodicity and time interval as used in in-center programs for 8 weeks.  Some patients 
(10/32) were called monthly and were asked about their condition and training regimen.  
Subjects in S completed logs reporting date and duration of training sessions. 
 
Activity scale for Study I 
Activity was assessed by a questionnaire previously used in this laboratory (42), 
which includes questions evaluating difficulty in walking, climbing stairs, dressing, cleaning, 
shopping, housekeeping, working and hobbies.  Daily activity was scored on a 0-3 scale (0-
not limited, 1-moderately limited, 2-severely limited, 3-not able to do) for 8 items before and 
after training with a total score of 0 to 24 (≤5: good activity, 5-8: moderately reduced activity, 
8-16: severely reduced activity, >16: homebound). 
 
Data collection for Study II 
A 16-bit A/D converter digitized (WinDaq Acquisition Version 2.68, Dataq 
Instruments, Akron, Ohio, USA) at 100 Hz the analog flow signal from the exercise system, 
and then it was stored on a personal computer for futher analysis.  The flow signal was 
integrated to volume and the volume was calibrated subsequently.  The system calibration 
was succesful for linearity and to have zero intercept; that is why a scalar multiplicative 
calibration factor was used to adjust the computed expired volume from the flow signal.  
 
Breath-cycle detection for Study II 
 Because flow towards the end of expiration often fluctuates around zero, it was 
unsatisfactory to apply a “crossing zero flow” criterion to distinguish the start and the end of 
a breath cycle.  To overcome this, we moved the trigger-threshold to a small negative flow (-
0.15 L/s).  The start of expiration was defined as the point at which flow exceeded this 
threshold and remained in a clear positive trend in the next 140 ms.  Similarly, the start of 
inspiration was defined, as the point at which flow achieved this negative threshold, and was 
followed by clear negative trend in the next 140 ms. After the computerized analysis, each 
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data set was visually inspected for accuracy and validity of breathing phase change and if 
necessary it was manually corrected, as a validation procedure for breath cycle detection.  
 
Computing the tidal volume during spontaneous respiration for Study II 
 Tidal volume calculation was defined by resetting the volume integration with the 
Riemann Sums method at the start of each expiration (43).  The resetting integration 
compensated for predictable inequalities in inspiratory and expiratory integrated volumes 
when the respiratory quotient differs from unity.  
 
Computing the rectangular area ratio (RAR) for Study II 
Spontaneous expiratory flow-volume curves were analyzed breath-by-breath, and a 
geometric quantification was performed by custom-made Sigma Plot 10.0 transform 
functions (SPSS Science, Chicago, IL).  The geometric analysis was based on the changes in 
the shape of the descending phase of the expiratory limb of the SEFV curves.  The geometric 
analysis was defined as an identification of the intra-breath coordinates of two critical 
anchoring points: (A) the maximum spontaneous expiratory flow (
maxV& ) and (B) the point at 
which the expiratory flow takes a sharp decline signaling the beginning of inspiration ( EEV& , 
‘end-expiratory flow’) (Fig. 4). EEV& was defined as the point associated with the greatest 
difference between the slopes of adjacent 20 ms segments of the flow-volume curve during 
the last 0.25 seconds of expiration.  These two points were used to make a rectangle from 
which the breath-by-breath rectangular area ratio (RAR) in the following way was calculated 
as a measure of concavity defined: 
.
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where 
max@ VV & and EEVV &@ are the volumes at maxV& and EEV& , respectively and VT is tidal 
volume. Values of RAR below 0.5 define concavity while values above 0.5 show convexity.  
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This quantification makes comparisons of curvatures between different loops possible (Fig. 
4).  
All computer algorithms were developed for breath detection and for the breath-by-
breath determination of the parameters of the geometric analysis (RAR, maxV& , EEV&
 
and the 
relative position of maxV& ) using SigmaPlot transform functions (SPSS Science, Chicago, IL, 
USA). We calculated the 30-second bin average values. 
 
Statistical analysis 
The results are presented as mean±SD in the text and tables and plotted as 
mean±SEM in the figures, unless signaled otherwise. Group means were analized by 
unpaired two-tailed Student’s t-tests.  To compare means between groups before and after 
rehabilitation (study I) or at different levels of exercise (study II), we used two-way repeated 
measures ANOVA with Holm-Sidak post hoc analysis of variance to define any individual 
significance.  The statistical analyses were performed in SigmaStat 3.5 (SPSS Science).  
Statistical significance was accepted at P<0.05.  Distribution around the mean was expressed 
±SD, except in figures, where ±SE was used.   Distributions were tested for normality by 
Kolmogorov-Smirnov test and significance was accepted if P<0.05.  We targeted in study I 
the study sample size based on discerning differences in the change in peak oxygen uptake in 
the incremental test among groups as the primary outcome.  We used ANOVA statistics for 
the 3 groups and asserted that the minimum clinically important difference (44) between 
groups was 0.1 L/min, the expected standard deviation of change in peak oxygen uptake 
among subjects was 0.1 L/min, and utilized a power of 0.8 and α=0.05.  This analysis 
indicated that 20 subjects in each group would be required. 
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Results 
 
Study I 
In the supervised groups, 31 of 39 subjects were trained 3 times/week (total 24 
sessions) (Figure 1).  Five of 22 continuous training patients performed fewer sessions than 
the target, averaging 20 sessions (Figure 1). In the interval group 3 of 17 patients performed 
fewer sessions than the target, also averaging 20 sessions (Figure 1).  Training work rate of 
supervised continuous training was 74±28W (80% peak work rate).  In the interval group 
work rate fluctuated between 79±25W (90% peak work rate) and 44±14W (50% peak work 
rate).    Therefore over the course of a session, the average work rate was 80% of peak work 
rate in the C group and 77% in the I group.  The actual mean work in the two groups were 
161.6±50.6 kJ and 199.8±74.8 kJ in the I and C groups, respectively.  The activity logs in 
self-paced groups revealed average daily training duration was 30±6 minutes and average 
sessions/week was 3.5±0.2.  All subjects completed the training protocol. There were no 
adverse events according to the study protocol. 
There were no significant differences in demographics for study participants among 
the three groups (Table 1).  Lung function showed moderate obstruction and hyperinflation at 
baseline without significant differences among groups.  There were no significant changes 
after training (Table 2).   
Percent predicted peak work rate (45) was 67%, 67%, 68% in C, I and S groups, 
respectively, before training.  Peak EV&  and EV& /MVV ratio before training did not differ 
significantly among groups (Table 3), suggesting similar ventilatory limitation.  Further 
supporting this, peak exercise Borg dyspnea scores did not differ among groups.  Peak work 
rate increased significantly in C and I in response to exercise training, but not in S (Figure 2) 
with increases in C and I groups (12±9 and 14±12W, respectively, p<0.05 for each) that were 
greater than in S (3 ± 12W, NS).  A similar tendency was detectable in peak 2VO& , increased 
significantly in C and I groups, but not in S; however, differences among groups were not 
statistically significant (Figure 2).  LAT increased significantly in supervised groups, 
averaging 0.08±0.10 and 0.10±0.15L/min in C and I, but not in S (0.04±0.21L/min), while 
these differences did not achieve the statistical significance.  Peak EV& , heart rate, blood 
gases, oxygen saturation (SpO2) and Borg dyspnea, and leg effort scores did not change 
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significantly as a result of training in any group, showing that exercise led to similar 
physiologic limitations. 
Isotime responses are presented in Table 3 and Figure 3.  There were significant 
reductions in isotime ventilatory equivalent for CO2 ( EV& / 2VCO& ) and respiratory rate (f) and 
non-significant reduction tendencies in isotime EV& and heart rate (HR) in the supervised 
constant intensity group (by an average of 3 units, 3 breaths/min, 2 Liter/min and 9 
beats/min, respectively).  In contrast, in isotime changes in the I and S groups were small, 
and did not achieve statistical significance.   
The activity questionnaire showed reduced activity (average score: 11) at baseline in 
all groups.  After training, there was a significant improvement (i.e., decrease) in activity 
score in each group (C: 11.5±0.7 vs. 9.0±2.8, I: 10.4±2.4 vs. 7.2±2.1, S:  11.6±2.3 vs. 
7.0±1.9; in C, I and S groups; each p<0.01 before vs. after training) but differences in 
improvement among groups did not achieve a statistical significance. 
Study II 
Subject characteristics and exercise tolerance 
The demographic and resting spirometric values of the study population are presented 
in Table 4. The obstruction was moderate to severe showed by resting pulmonary function in 
the COPD patients. There were no statistically significant differences in age, height, and 
weight between the healthy and COPD groups in study II.  
COPD patients had a severely impaired exercise tolerance with marked ventilatory 
limitation as characterized by high end-exercise minute ventilation ( E peakV& ) to MVV ratio 
( E peakV& /MVV; 95±21% vs. 54±8% in the COPD patients vs. healthy individuals, respectively; 
P<0.05) whilst healthy individuals suffered from no such difficulties (Table 5).  
Breath detection 
Each data set was visually inspected for accuracy and validity of breathing phase 
change and if necessary it was manually corrected, as a validation procedure for breath cycle 
detection. We count the number of false positive and false negative detections, and calculate 
the sensitivity for detecting the start of expirations and inspirations. Among the 29 performed 
test, the false positive detection rate for inspiration and expiration was 1.2±1.1% and 
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1.9±1.3%, respectively. The false negative rate was 4.2±4.4% for inspirations and 5.0±4.5% 
for expirations. The data analysis was calculated after manual correction of all these errors in 
breath detection.  
Progressive change in the shape of the spontaneous flow-volume curve during exercise 
Figure 4 shows the expiratory loop of the flow-volume curve in a typical healthy 
individual (upper row) and in a COPD patient (lower row) at rest and at 25%, 75%, and 
100% of peak work rate.  The shape of the expiratory limb of the SEFV curve at rest and 
during exercise in the healthy individual, which is reflected by an RAR ≥0.5 (Fig.4, upper 
row).  But in the COPD patient, the expiratory limb of the SEFV curve becomes concave at 
75% peak work rate (RAR=0.4) and shows more concavity at peak exercise (RAR=0.34) 
(Fig.4, lower row).  Note that both the normal individual and the COPD patient increase 
intrabreath maxV&  and EEV&  with progression of exercise, and that the position of maxV&  stays in 
the middle segment of the tidal volume in the healthy subject even at peak exercise, while 
within the first quarter of expiration in the COPD patient from early stages of exercise. 
Figure 5 illustrates the breath-by-breath analysis of the RAR, maxV&  and EEV&  during the 
time course of unloaded cycling and incremental exercise in a healthy individual (upper 
panel) and a COPD patient (lower panel).  Superimposed on these plots are smoothed curves 
calculated by a negative exponential smoothing method (46).  The RAR smoothed curve of a 
healthy individual was above the 0.5 line (in the upper panel of Figure 5) at rest and 
throughout the exercise, reflecting the convexity of the SEFV curve during the whole test. In 
the lower panel of Figure 5 it is shown that during unloaded cycling and early into the ramp 
exercise the RAR smoothed curve in the COPD patient was at or above the 0.5 line, reflecting 
the convex shape of the expiratory limb of the SEFV curve.  At about 5 minutes before peak 
exercise, the RAR smooth curve fell below 0.5, showing that the SEFV curve became 
concave.  The RAR finally reached a nadir of 0.37 at peak exercise in this COPD patient.  It 
can be seen in this figure, at the time when the RAR smoothed curve fell below 0.5, maxV&  
reached about 1.5 L/sec and EEV&  was appreciably above the resting level.  
            Figure 6 shows the mean RAR plotted as a function of VE max/MVV at rest and during 
exercise: at 6, 4, and 2 minutes before end-exercise and at end-exercise, in both healthy and 
COPD individuals. In healthy individuals (empty circles), RAR at 6 minutes before end-
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exercise dropped below the RAR at rest but then progressively increased during the rest of 
the test; RAR remained significantly above 0.5 in the whole duration of exercise. In marked 
contrast, average RAR of COPD patients at rest was slightly higher than 0.5 but showed a 
continuous fall throughout the exercise (average peak exercise value 0.46±0.06). On average, 
the COPD patients achieved more than 90% of their respiratory reserve (i.e. they are 
ventilatory limited) at peak exercise (Figure 6).  
The number of COPD patients who showed average RAR during the last 30 seconds 
before exercise end of <0.5 was analysed.  Fourteen of seventeen COPD patients manifested 
averaged RAR<0.5 at end exercise, while in two of the 14 patients the nadir value was only 
slightly below 0.5 (approximately 0.49). We try to find responsible factors for the failure to 
develop substantial concavity in these five COPD patients.  These patients have a wider range 
of disease severity (i.e. FEV1% predicted of 33, 34, 45, 52 and 56); hence, resting lung 
function does not seem to be a principal determination factor of concavity in the SEFV curve 
during exercise.  Two of the five subjects presented ventilatory limitation (peak 
VE/MVV%=103 and 109) and three had substantial ventilatory reserve (mean 
VE/MVV%=70±8) at peak exercise.  Despite to the other 12 COPD patients who developed 
definite concavity during exercise, these five patients indicated less dyspnea (Borg dyspnea 
score: 4.8±1.5 vs. 5.5±1.9) and more leg fatigue (Borg leg score: 5.8±1.6 vs. 4.8±2.0) at peak 
exercise, while these differences did not reach a statistical significance.  All healthy 
individuals generated RAR smoothed curve remained above 0.5 during the whole exercise. 
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Discussion 
Investigating strategies to improve exercise tolerance in COPD, we compared three 
rehabilitative training strategies in study I and defined their effectiveness in increasing peak 
exercise tolerance and in different physiological training variables.  The effect of two types of 
supervised training modalities, like continuous and interval training; were compared to a self-
paced, home-based program.  Peak work rate in an incremental exercise test showed 
significant imporvement in the supervised groups, with little difference between C and I 
groups.  Both supervised groups exhibited similar significant increases in 2peakVO& and LAT.  
Self-paced training yielded only small and insignificant improvements in these measures.  
Analysis of variance revealed that the difference in increase in peak work rate, but not 
2peakVO& and LAT between the supervised groups, and the self-paced groups achieved 
statistical significance.  
Related to exercise intolerance in study II we have shown that our novel, 
computerized method allows characterization of the genesis and development of progressive 
expiratory flow limitation that occurs during exercise in COPD patients in a non-invasive and 
unobtrusive way.  To the best of our knowledge, this is the first approach on a breath-by-
breath basis that allows quantification of EFL by characterizing the profile of the SEFV 
curve.  Our method does not require additional instrumentation beyond the flow sensor and 
digitizing equipment for the analog output of the flow sensor, in opposite of NEP 
measurement and the forced oscillation technique.  The algorithm for this analysis might be 
implemented as a software module, and easily can be used in preexisting computerized 
cardiopulmonary exercise systems.  Furthermore, it does not require invasive maneuvers and 
provides a fully quantitative, objective and dynamic measurement of developing flow 
limitation during exercise on a breath-by-breath basis. 
Activity becomes progressively reduced by shortness of breath, and it can lead to 
deconditioning in COPD patients (1, 2).  Aerobic enzyme concentrations, mitochondrial 
density, muscle fiber-to-capillary ratio decrease, and there is reduction of muscle mass and 
type I fiber fraction in these type of COPD patient (47).  
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According to previous studies, COPD patients could achieve a physiological training 
effect; it has now been clearly shown that high intensity endurance training yields increases 
in 2peakVO&  (3) and the ability to sustain a given work rate (3).  Training can result in an 
increase in the muscle capillary-to-fiber ratio leading to a reduction in capillary to 
mitochondria diffusion distance (48) and increasing oxidative enzyme content and myoglobin 
levels (48), which was detected by muscle biopsy.  
 Optimal strategies to increase exercise tolerance through rehabilitative exercise 
were sought.  A key finding was that high intensity training achieved greater physiologic  
effect than low intensity training (3).  Recent studies have focused on strategies allowing 
COPD patients to exercise at higher training work rates; in randomized double-blind trials 
oxygen administration (49,50) and bronchodilator therapy (51) have been shown to increase 
rehabilitative exercise training effectiveness (52).   
Home-based exercise programs have been found effective in increasing exercise 
tolerance and quality of life (5), but the relative effectiveness compared to supervised 
programs can be questionable.  Home-based programs have discernable disadvantages.  
Frequent encouragement and instruction by trained rehabilitation personnel can be crucial  
adjunct to rehabilitation.  Ongoing interaction with patients similarly afflicted is posited to 
assist in motivating patients to comply with rehabilitative therapy.  It has clinical importance 
to compare effectiveness of home-based programs with supervised group programs; 
previously only two studies have been reported in this field (6, 7).   
COPD patients have been compared in a 12-week program with twice-weekly 
sessions of either home-based (15 patients) or in-center exercise (15 patients) by Strijbos et 
al. (7).   Equal improvements in exercise capacity and reduction in breathlessness and leg 
fatigue have been found at the program’s end and 3 months later in the two groups.  
However, some benefits (exercise capacity and Borg dyspnea score) persisted to a greater 
extent in the home-based program after 18 months. It has been an important study feature that 
therapists visited the home for each exercise session; this is not practical in many settings and 
is not a general set-up of most home-based programs that have been reported.  Puente-Maestu 
et al. have compared responses of 41 COPD patients to 8 weeks of in-center rehabilitation 4 
times/week vs. a home-based program with weekly in-center visits to maintain adherence (6).  
Estimated mean training work rate has definitely been higher in the in-center rehabilitation 
group and exercise tolerance measures (exercise duration, 2peakVO& , heart rate, isotime EV& , 
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2VCO&  and lactate accumulation) have also shown greater improvement in the in-center 
program.  
 In our study, the self-paced program employed was more similar to that of Puente-
Maestu et al. (6) than to that of Strijbos et al. (7) in that in home rehabilitation there were no 
personnel visits.  Like Puente-Maestu, we found only small non-significant trends in 
physiological training measures.  While home-based training may indicate of improvement 
the patient’s perception of activity level (as indicated by our activity questionnaire), it seems 
inferior to supervised training in improving exercise endurance.  Only small, non-significant 
improvement in peak exercise capacity, ventilatory, cardiovascular and metabolic responses 
was detected; improvement in peak exercise tolerance was significantly less than in the 
supervised groups.  We suspect that supervised training in a supportive environment in the 
presence of others similarly afflicted results in superior training results.  
Training intensity is determined by the effectivity of interval training as well as its 
effectiveness in inducing training effects in the exercising muscles.  Traditionally, it has been 
shown that below “critical training intensity” there is no achieved training effect, no matter 
how long the training proceeds (53).  Above this threshold, progressively higher intensities 
achieve progressively greater training effects, and exercise training can reduce dynamic 
hyperinflation of COPD patients (54), although it is not certain that this relationship is linear.  
If, for example, continuous training intensity performed at the critical training intensity is 
compared with interval training where intensity fluctuates below and substantially above the 
critical intensity, it is reasonable to expect that interval training will be more effective.  
Alternately, if continuous training set at a work rate above the critical training intensity, and 
it is compared to interval training with work rate fluctuating around this mean but always 
remaining above the critical intensity, it is difficult to predict which will be more effective 
(possibility the continuous training will be more effective than the interval training).  It is 
difficult to predict which regimen will be better tolerated in the sense that the total tolerable 
work may be greater with one or the other strategy.    
Coppoolse et al. have studied 21 COPD patients randomized to a continuous or 
interval training profile with the same total work per session performing an 8-week 5-
session/week, 30-minute/session exercise program (4).  Exercise testing has demonstrated 
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that, for most response measures, physiologic changes have been more marked in the 
continuous training group.  
Vogiatzis et al. have studied 36 COPD patients who performed in endurance training 
with 40-minute sessions held twice weekly.  Subjects have been randomized into two groups, 
a constant work rate group (50% of peak work rate) or an interval group (30 seconds at 100% 
of peak work rate alternating with 30 seconds of rest) (8).  Physiologic benefits have been 
detected in both groups with no clinically important difference.   
 Puhan et al. (55) has recently found no significant difference in the improvement of 
exercise capacity and quality of life of COPD patients performing interval or constant work 
rate training.  However, the work intensities set in this study have been somewhat lower than 
the ones used in previous studies (4, 8) or in the present study: training work rate in the 
constant work rate group was only 57% of peak work rate achieved in an incremental test, 
and the total work per session of those performing interval training was only 76% of that 
performed by the constant work rate training group.  In addition, the duration of the training 
sessions was only 20 minutes in either group.      
 In the present study both supervised training groups had high intensity work rate 
profiles.  The continuous training group exercised at 80% peak work rate in an incremental 
exercise test.  This is similar to the strategy employed previously (3) and is a near-maximal 
target (56).  Interval training changed to a substantial fraction of the time (2/3) to be spent at 
an even higher training intensity: 90% peak work rate, and another 1/3 spent at lower 
intensity (50% peak work rate) phase.  The average exercise intensity was therefore 77% of 
peak work rate and similar to that of the continuous work rate group.  Interval and continuous 
work rate profiles yielded similar physiologic response changes, and therefore, similar 
training effects as it can be seen in in Figure 1 and 2. 
  An additional information was that in both supervised groups, exercise intensity was 
held constant during the training program in order to make a strict comparison between the 
two strategies.  It differs from the most previous reports of exercise training in COPD, in 
which training intensity has been increased as tolerated during the intervention.  Substantially 
higher training work rates can be set in the latter strategy as the program proceeds (e.g., 
patients are able to exercise for the entire session at work rates approximating the peak in pre-
training incremental exercise testing) (56).  It can be a reason why training-induced increases 
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in the supervised groups in, for example, 2peakVO& are somewhat less in our study compared to 
some other COPD training studies (4, 57). 
Previous analyses compared to our new quantitative method have been mainly limited 
by the shape of spontaneous flow-volume curve to qualitative inspection.  A non-sinusoidal 
expiratory flow pattern was characteristic of obstruction, and pointed out that as EFL 
progresses the maxV&  is reached earlier in the tidal breath reported by Morris and Lane (58).  
Spontaneous flow-volume profiles of anaesthetized patients has been  monitored by 
Bardoczky and d’Hollander, pointing out the “bowing configuration” in the expiratory limb 
as an indication of diffuse obstruction (59).  Previous analysis found relation between the 
flow limitation and the presence of concavity of the expiratory limb of the flow-volume loops 
(60).  Baydur and Milic-Emili could detect the flow-volume shape in association with the 
NEP method qualitatively (60) and SEFV curve concavity in patients with a high percentage 
of tidal volume exhibiting flow-limitation monitored according to NEP; two-thirds of the 
patients with SEFV curve concavity have been reported with >50% of tidal volume 
exhibiting flow-limitation, and half of the patients showing concavity had >70% of tidal 
volume exhibiting flow limitation. 
In our study, 14 of 17 COPD patients performed a value of RAR <0.5 before peak 
exercise.  Althought, five subjects with low FEV1 did not show substantial concavity in their 
SEFV curve.  None of the normal subjects had the RAR smoothed curve drop below 0.5 at 
any point of exercise.  Comparing an age-matched control group, we demonstrated the real 
difference considering the possibility that the normally occurring decrease in elastic recoil 
with ageing might be associated with these configuration changes.  
There is, however, a wide range of subjects who achieved ‘minimal’ RAR at peak exercise in 
the COPD group, and it is worthwhile to consider possible mechanisms of concavity that 
might lead to this variability.  Several factors might be crucial to lead to concavity of the 
SEFV curve.  Rapid drop in expiratory flow rate can cause concavity in the flow-volume loop 
demonstrating dynamic airway compression (23,29,33).  Rapid and shallow breathing 
adopted by COPD patients augments the drop in expiratory flow rate, which is at a frequency 
that limits effective ventilation to lung compartments with short time constants.  Our data 
support the observation of Morris et al. (58), that as maxV&  rises during exercise, there is a shift 
of the position of the maxV&  to move in earlier position in the expired volume.  High 
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intrathoracic pressures achieved during expiration might lead to gas compression and a result 
of dynamic airway compression (24).  Futhermore, gas compression might occur in the 
presence of expiratory flow limitation (24, 28).  An increasing role of active expiration in 
moderate to severe COPD patients and the configurational changes might also be consistent.  
Further studies are warranted to determine the relative contribution of these potential 
mechanisms. 
One of the critical development tasks for this analysis was the “breath cycle 
determination” algorithm.  Using a slightly negative threshold is valuable to eliminate the 
influence of noisy flow signal toward the end of expiration.  Post-detection visual inspection 
of approximately 14,000 flow-volume loops demonstrated that using a slightly negative flow 
threshold to detect the beginning and end of expiration we achieved a low false positive and 
false negative rate in determining both inspirations and expirations.  This finding suggests 
that in subsequent studies, visual confirmation of accuracy of breath detection by this 
algorithm will not be needed.  
Accurate determination of the anchoring points ( maxV&  and EEV& ) has a potential 
limitation of RAR measurement technique because of noise in the expiratory flow signal.  
Breath-by-breath physiologic changes in the exhalation can be other possible reasons for the 
variability in RAR, which results inaccuracy of concavity or convexity of the expiratory limb 
of SEFV curve.   Furthermore, we observed that the configuration of SEFV curve sometimes 
varies considerably between subsequent breaths that might lead to errors in determining the 
critical anchoring points for the calculation of RAR.  Interestingly, the breath-to-breath 
variability was generally greater in healthy subjects than in COPD patients.  We suppose that 
part of this variability might come from random changes in compliance or vibrations within 
the airways that is less characteristic in COPD.  Additionally, the SEFV curve adopts more 
convex configuration in healthy subjects (58), from which it is more difficult to separate the 
intrabreath peak- and end-expiratory flow, leading to variability in RAR calculations. In order 
to minimize the effect of breath-by-breath variability, we smoothed the breath-by-breath data 
using a single component exponential smoothing method (61) which allowed characterization 
of trends. Another way of diminishing the effect of breath-to-breath configuration changes of 
the SEFV curve would be to average several consecutive breaths and calculate the RAR 
based on the averaged curves. A third way of dealing with this variability would be to 
exclude from further analysis RAR values that were outliers from the general trend.  These 
methods might be explored in future studies. 
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In summary, the training study supports the concept that in-center high intensity 
supervised rehabilitation programs can be more effective as shown by physiologic evidence 
of improved exercise tolerance than home-based unsupervised programs, while some of the 
measured physiologic variables did not achieve statistical significance.  We could not 
demonstrate difference in effectiveness of interval training as compared with constant work 
rate training with similar total work per session. The interval training might have a greater 
training effect presumably because of the higher muscle tension during the exercise periods. 
In future studies other interval work rate strategies might be found, which might be more 
effective.  In theory interval training has less load for the pulmonary vasculature (especially 
important in pulmonary hypertension), and patients can tolerate more easally this training 
modality (62). 
According to exercise intolerance, flow limitation, the quantification of concavity of 
the expiratory limb of the SEFV curve by means of calculation of the RAR breath-by-breath 
seems to be a valuable method for assessing development of EFL in COPD patients.  The 
shape change of the loops develops as a consquence of progressively active expiration and 
dynamic airway compression.  Hence, the measurement of RAR seems to have clinical 
importance in routine assessment of progressive flow limitation in COPD and may show a 
factor to critical ventilatory limitation and dyspnea.  Further studies are needed to compare 
the results of this breath-by-breath quantification with other methods of EFL determination 
such as the NEP method and the forced oscillation technique.   Further research is also 
needed to explore the validity and reliability of this method in stratification of COPD patients 
across the total range of disease severity.  There might be an association between dynamic 
hyperinflation measurement and the observed SEFV configuration changes.   
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Tables 
Table 1. Demographic characteristics of Study I participants 
 
 Supervised 
continuous (C) group 
(n=22) 
Supervised interval (I) 
group 
(n=17) 
Self-paced (S) group 
(n=32) 
Age (year) 61 ± 12 67 ± 10 60 ± 12 
Height (cm) 167 ± 7 166 ± 7 168 ± 6 
Body weight (kg) 73 ± 12 67 ±10 71 ± 12 
BMI (kg/m2) 26 ± 4 25 ± 4 25 ± 4 
Male:Female 19:3 11:6 25:7 
Mean±SD;  BMI: body mass index 
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Table 2. Resting lung function and blood gases before and after rehabilitation in Study I 
 
Mean±SD; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; TLC: 
total lung capacity; FRC: functional residual capacity; RV: residual volume; DLCO: diffusion 
capacity of carbon monoxide; PaO2: arterial partial O2 pressure; PaCO2: arterial partial CO2 
pressure. 
 
 
 
Supervised continuous 
(C) group (n=22) 
Supervised interval (I) 
group (n=17) 
Self-paced (S) group 
(n=32) 
Lung function 
Before 
training 
After 
training 
Before 
training 
After 
training 
Before 
training 
After 
training 
FEV1 (liter)   1.5 ± 0.5   1.5 ± 0.5   1.7 ± 0.7   1.8 ± 0.7   1.5 ± 0.5   1.5 ± 0.5 
FEV1 (%pred)   51 ± 16   52 ± 17   64 ± 29   66 ± 23   52 ± 16   52 ± 17 
FVC (liter)   2.9  0.8   3.0 ± 0.8   3.0 ± 0.7   3.1 ± 0.8   3.0 ± 0.7   3.0 ± 0.7 
FVC (%pred)   82 ± 17   82 ± 15   90 ± 23   93 ± 22   84 ± 17   86 ± 19 
FEV1/FVC (%)   50 ± 12   49 ± 12   57 ± 17   57 ± 16   50 ± 13   49 ± 12 
TLC (%pred) 110 ± 16 110 ± 17 116 ± 13 111 ± 21 119 ± 16 117 ± 21 
FRC (%pred) 136 ± 33 139 ± 34 147 ± 33 140 ± 39 157 ± 30 153 ± 40 
RV (%pred) 164 ± 48 160 ± 42 171 ± 53 149 ± 46 179 ± 44 176 ± 52 
RV/TLC (%)   54 ± 10   52 ± 10   54 ± 13 48 ± 7   56 ± 11   55 ± 10 
DLCO (%pred)   67 ± 17   69 ± 20   67 ± 26   65 ± 13   62 ± 26   63 ± 21 
PaO2rest (mmHg)      65 ± 8      64 ± 6      67 ± 7   73 ± 15 66 ± 7 65 ± 7 
PaCO2rest (mmHg) 43 ± 4      42 ± 4      42 ± 7 39 ± 5 42 ± 5 43 ± 6 
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Table 3. Exercise testing results before and after rehabilitation in Study I 
  Supervised continuous (C) group Supervised Interval (I) group Self-paced (S) group 
  Before training After training Before training After training Before training After training 
2VO&  (Liter/min) 1.17±0.40 1.27±0.40*  1.10±0.31 1.18±0.36* 1.12±0.37 1.17±0.35 
EV&
 
(Liter/min)   51 ± 17   51 ± 16   46 ± 11   49 ± 14   48 ± 12    47 ± 11 
f (breath/min)   45 ± 7   41 ± 7*   44 ± 6   42 ± 7   44 ± 6   41 ± 7* 
HR (beat/min) 138 ± 26 133 ± 22 130 ± 17 129 ± 36 139 ± 24 138 ± 22 
SpO2 (%)   93 ± 2   94 ± 2   92 ± 6   94 ± 2   92 ± 2   92 ± 4 
EV& / 2VCO&    40 ± 5   37 ± 4   39 ± 5   38 ± 4   43 ± 10   41 ± 7 
EV& /MVV (%)   90 ± 24   89 ± 22   68 ± 29   76 ± 24   85 ± 19   83 ± 22 
PaO2 (mmHg)   71 ± 10   70 ± 10   67 ± 7   70 ± 10   68 ± 8   68 ± 8 
PaCO2 (mmHg)   43 ± 6   44 ± 7   42 ± 7   42 ± 5   44 ± 5   43 ± 6 
Borg (dyspnoea)  6.4 ± 2.5  5.7 ± 2.7  6.6 ± 2.2   6.0 ± 2.1  7.4 ± 1.8 6.7 ± 2.5 
 
 
 
Peak 
Borg (leg fatigue)  6.2 ± 2.9  5.9 ± 3.1  6.9 ± 2.2  6.1 ± 2.5  6.6 ± 2.3 6.3 ± 2.6 
2VO&  (Liter/min) 0.82±0.22 0.92±0.24* 0.83±0.29 0.96±0.28* 0.84±0.25 0.91±0.25 
EV&
 
(Liter/min)   32 ± 7   36 ± 7   32 ± 8   35 ± 9   33 ± 7   36 ± 7 
f (breath/min)   27 ± 5   27 ± 6   29 ± 6   30 ± 5   26 ± 4   27 ± 4 
HR (beat/min) 119 ± 23 111 ± 23 110 ± 19 114 ± 18 120 ± 20 121 ± 19 
SpO2 (%)   93 ± 2   94 ± 2   94 ± 2   93 ± 6   93 ± 2   93 ± 4 
 
 
LAT 
EV& / 2VCO&    41 ± 6   38 ± 11   41 ± 5   40 ± 6   43 ± 10   43 ± 8 
2VO&  (Liter/min) 1.14±0.37  1.15±0.35 1.07±0.26 1.06±0.34 1.10±0.35 1.11±0.33 
EV&
 
(Liter/min)   48 ± 16   46 ± 16   42 ± 10   42 ± 14   45 ± 10   44 ± 10 
f (breath/min)  33 ± 6   30 ± 6*   33 ± 7   31 ± 7   31 ± 6   31 ± 7 
HR (beat/min) 139 ± 24 130 ± 19 127 ± 17 125 ± 20 136 ± 23 133 ± 21 
SpO2 (%)   93 ± 3   93 ± 3   93 ± 3   92 ± 5   92 ± 3   92 ± 4 
 
 
Isotime 
EV& / 2VCO&    41 ± 6   38 ± 5*   38 ± 7   41 ± 8   41 ± 8   41 ± 7  
Mean±SD, *p<0.05; 2VO& : oxygen uptake; EV& : minute ventilation; f: breathing rate; HR: heart rate; SpO2: oxygen saturation; EV& / 2VCO& : 
ventilatory equivalent; MVV= FEV1x40: maximal voluntary ventilation; LAT: lactate anaerobic threshold. 
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Table 4. Demographic and pulmonary function characteristics of Study II subjects 
 Healthy  
(n=12) 
COPD  
(n=17) 
Age (years) 60± 9 63±10 
Height (cm) 169±9 169±10 
Weight (kg) 74±15 77±12 
FEV1 (L) 3.1±0.8 1.1±0.5* 
FEV1 %pred. 104±13 39±12* 
FVC (L) 4.0±1.0 2.8±1.1* 
FVC  %pred. 103±14 77±20* 
FEV1/FVC% 77±4 40±7* 
MVV (L) 123.5±31.1 43.7±18.9* 
PEF (L/s) 7.6±1.9 3.3±0.9* 
TLC (L) 6.3±1.3 7.1±2.1 
TLC %Pred. 108±12.9 113±17.8 
FRC (L) 3.2±0.7 4.8±1.5* 
FRC %Pred. 104±23.1 146±29.4* 
RV (L) 2.3±0.5 3.8±1.4* 
RV %Pred. 107±16.8 163±46.8* 
Mean±SD, * P<0.05; %pred values in pulmonary function were calculated according to 
NHANES III standard38. FEV1: forced expiratory volume in the 1st second; FVC: forced vital 
capacity; MVV: maximum voluntary ventilation (FEV1 X 40)40; PEF: peak expiratory flow; 
TLC: total lung capacity; FRC: functional residual capacity; RV: residual volume.  
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Table 5. Exercise tolerance and end-exercise ventilatory characterization (Mean ± SD) in 
Study II. 
 
 Healthy  
(n=12) 
COPD  
(n=17) 
Peak WR (Watts) 145±38 68±35* 
2peakVO&  (L/min) 1.75±0.49 1.14±0.37* 
EV& peak (L/min) 66±19 40±14* 
EV& peak/MVV (%) 54±8 95±21* 
VT (L) at end-exercise 2.1±0.54 1.2±0.38* 
RAR at end-exercise 0.61±0.05 0.46±0.06* 
 
Mean±SD; * P<0.05; Peak WR: peak work rate in the incremental test; 2peakVO& : peak oxygen 
uptake at end exercise; EV& peak : peak minute ventilation; EV& /MVV : ratio of peak minute 
ventilation and maximal voluntary ventilation (MVV=FEV1*40) 40; RAR: rectangular area 
ratio; VT: tidal volume.  
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Figure legends for Study I 
 
Figure 1: Flow of participants through each study stage. 
 
Figure 2: Change in peak oxygen uptake ( 2VO& ), the lactic acidosis threshold (LAT) and 
peak work rate as a result of training in the three training groups.  
*p<0.05 vs. self-paced training, errors bars represent ±SE  
 
Figure 3: Change in isotime responses as a result of training during an incremental 
exercise test in the three training groups. EV& , minute ventilation; f, respiratory rate; HR, 
heart rate; EV& / 2VCO& , ventilatory equivalent for carbon dioxide.  
*:p<0.05 vs. supervised continuous training, #:p<0.05 vs. self-paced training, error bars 
represents ±SE. 
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Figure 1.   
 
 
 
79 screened patients: 
8 excluded: - 1 psychiatric disease  
      - 4 ischemic heart disease       
      - 3 exercise limiting joint disease 
Unsupervised training 
group (n=32) 
Supervised training 
group (n=39) 
Home-based, self 
paced training 
High intensity, 
continuous training 
(n=22) 
Interval training 
(n=17) 
 
30 minutes period of cycling for 2 minutes 
at 90% followed by 1 minute at 50% peak 
work rate, with 7.5 min warm-up and cool-
down phase at 50 % of peak work rate, 3 
times/week, 4 out of 17 patients for the 
first 9 sessions performed 70% intensity 
and 40% intensity phase then followed the 
protocol 
 
45 minutes walking or cycling or 
climbing on stairs, target 
duration was 30 minutes at start 
and it increased to 45 minutes 
Average duration: 30 ± 
6 minutes and average 
sessions/week: 3.5 ± 
0.2 
45 min cycling of 80 % peak work 
rate, 3 times/week, 7 out of 22 
patients allowed break sessions in 
every 10 minutes for 9 sessions 
(these patients started 65%peak 
work rate) then followed the 
protocol 
3 of 17 performed 
fewer sessions than 
the target (20 
instead of 24) 
5 of 22 performed 
fewer sessions than 
the target (20 
instead of 24) 
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Figure 2. 
 
  
44
 
Figure 3. 
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Figure legends for Study II: 
 
Figure 4.   Progression of the spontaneous flow-volume (SEFV) curve configuration during 
incremental exercise.  Top row: a healthy individual (FEV1=3.7 L, 81% predicted). Bottom 
row: a severe COPD patient (FEV1=1.0 L, 29% predicted). The shaded portion is the area 
used to calculate the rectangular area ratio (RAR); the triangle bounded by the dotted line, 
using the peak expiratory flow ( maxV& ) and the end expiratory flow ( EEV& ) as anchor points, 
represents a RAR of 0.5, demonstrating no curvature. The healthy individual has a RAR that 
remains above 0.5, indicating SEFV curves with consistently convex profiles at all exercise 
levels. The COPD patient displays a declining RAR that achieves a minimum of 0.34 at peak 
exercise, indicating a markedly concave SEFV curve configuration as exercise progresses. 
Note that both the normal individual and the COPD patient increase intrabreath maxV&  and  
EEV&  with progression of exercise and that the position of maxV&  stays in the middle segment of 
the tidal volume in the healthy subject, while remaining within the first quarter of expiration 
in the COPD patient.  PWR: peak work rate, WR: work rate, VE: minute ventilation, MVV: 
maximal voluntary ventilation calculated as FEV1*40. 
Figure 5.  Breath by breath time course (open circles) of rectangular area ratio (RAR), peak 
expiratory flow ( maxV& ) and end-expiratory flow ( EEV& ) during an incremental exercise test. The 
boldface lines represent smoothed data (exponential method 61). Note that the ordinate scales 
for maxV&  and EEV&  are different in order to better represent the changes.  Panel A: a healthy 
person (51 yrs, female, FEV1: 2.72 L (98% predicted)).  Panel B: a COPD patient (66 yrs, 
male, FEV1: 1.02 L (29% predicted)).  
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Figure 6.  Rectangular area ratio (RAR) responses occurring at rest and as exercise limitation 
is approached during incremental exercise in healthy individuals (n=12, open circles) and 
COPD patients (n=17, closed circles).  The abscissa presents mean VE/MVV at rest and at 6, 
4, 2 and 0 minutes prior to end-exercise from left to right, respectively. RAR values of COPD 
patients are lower at rest and at all phases of exercise as compared to normal, non-obstructed 
subjects (repeated measures ANOVA P<0.01). The RAR is significantly less than at rest 
starting 4 minutes before end-exercise (repeated measures ANOVA P<0.01). In normal 
subjects, RAR is significantly higher than at rest starting two minutes prior to end of exercise 
(repeated measures ANOVA P<0.01). The index of ventilatory limitation (VE/MVV x 100) 
approaches a value of 100% in the COPD patients but not in the healthy individuals. 
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Figure 4  
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Figure 5/A 
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Figure 5/B 
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